Intellectual Property India Publishes Patent Application for Design,synthesis And In-Vitro Evaluation Of Novel Benzothiazole Coumarin Scaffolds As Potent Cytotoxic Agents Against Hepg2 Cancer Cell Lines

MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202641060648 A) filed by Christ University on May 13, 2026, for Design,synthesis And In-Vitro Evaluation Of Novel Benzothiazole Coumarin Scaffolds As Potent Cytotoxic Agents Against Hepg2 Cancer Cell Lines.

Inventors include Amruta Kush Durgi; and Ajesh Vijayan.

The application for the patent was published on July 03, 2026, under issue no. 27/2026.

Abstract: Cancer is a life-threatening disease marked by uncontrolled cellular proliferation and invasion of surrounding tissues, leading to a significantly high mortality rate. Hence development of new bioactive compounds is essential in developing anticancer agents targeting multiple pathways involved in...